Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL.

Wang ML, Cohen JB, Shah NN, Jurczak W, Zinzani PL, Cheah CY, Ujjani CS, Koh Y, Kim WS, Nasta SD, Flinn I, Tessoulin B, Ma S, Alencar AJ, Lewis DJ, Woyach JA, Maddocks KJ, Patel K, Wang Y, Rhodes JM, Tam CS, Seymour JF, Nagai H, Vose JM, Fakhri B, Hoffmann MS, Hernandez-Ilizaliturri F, Zelenetz AD, Kumar A, Munir T, Tsai DE, Abada P, Balbas M, Li J, Wang D, Roeker LE, Eyre TA

Open source

DOI: 10.1002/ajh.70533
Published: 2026 Nov 4
Container: American journal of hematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70533,
  title = {Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL.},
  author = {Wang ML and Cohen JB and Shah NN and Jurczak W and Zinzani PL and Cheah CY and Ujjani CS and Koh Y and Kim WS and Nasta SD and Flinn I and Tessoulin B and Ma S and Alencar AJ and Lewis DJ and Woyach JA and Maddocks KJ and Patel K and Wang Y and Rhodes JM and Tam CS and Seymour JF and Nagai H and Vose JM and Fakhri B and Hoffmann MS and Hernandez-Ilizaliturri F and Zelenetz AD and Kumar A and Munir T and Tsai DE and Abada P and Balbas M and Li J and Wang D and Roeker LE and Eyre TA},
  year = {2026},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.70533},
  url = {https://doi.org/10.1002/ajh.70533}
}

RIS

TY  - JOUR
TI  - Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL.
AU  - Wang ML
AU  - Cohen JB
AU  - Shah NN
AU  - Jurczak W
AU  - Zinzani PL
AU  - Cheah CY
AU  - Ujjani CS
AU  - Koh Y
AU  - Kim WS
AU  - Nasta SD
AU  - Flinn I
AU  - Tessoulin B
AU  - Ma S
AU  - Alencar AJ
AU  - Lewis DJ
AU  - Woyach JA
AU  - Maddocks KJ
AU  - Patel K
AU  - Wang Y
AU  - Rhodes JM
AU  - Tam CS
AU  - Seymour JF
AU  - Nagai H
AU  - Vose JM
AU  - Fakhri B
AU  - Hoffmann MS
AU  - Hernandez-Ilizaliturri F
AU  - Zelenetz AD
AU  - Kumar A
AU  - Munir T
AU  - Tsai DE
AU  - Abada P
AU  - Balbas M
AU  - Li J
AU  - Wang D
AU  - Roeker LE
AU  - Eyre TA
PY  - 2026
JO  - American journal of hematology
DO  - 10.1002/ajh.70533
UR  - https://doi.org/10.1002/ajh.70533
ER  -

APA

ML, W., JB, C., NN, S., W, J., PL, Z., CY, C., CS, U., Y, K., WS, K., SD, N., I, F., B, T., S, M., AJ, A., DJ, L., JA, W., KJ, M., K, P., Y, W., JM, R., CS, T., JF, S., H, N., JM, V., B, F., MS, H., F, H., AD, Z., A, K., T, M., DE, T., P, A., M, B., J, L., D, W., LE, R., & TA, E. (2026). Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL.. American journal of hematology. https://doi.org/10.1002/ajh.70533

Source records

pubmed · retrieved 2026-11-10T12:51:34.551Z